NASDAQ:VRAX

Virax Biolabs Stock Faces a Make-or-Break Nasdaq Vote After a Wild Week

Virax Biolabs Stock Faces a Make-or-Break Nasdaq Vote After a Wild Week

Virax closed Friday at $0.2775, down 9.31%, but up 81% from May 15. Shareholders will vote June 5 on a 10-for-1 to 30-for-1 reverse share consolidation as the company faces a July 11 Nasdaq deadline to regain $1 minimum bid compliance. U.S. markets are closed Monday for Memorial Day, with trading to resume Tuesday. Armistice Capital disclosed a 4.99% stake in Virax earlier this month.
May 25, 2026

Stock Market Today

  • Red Mountain Mining Issues Retraction on Montana Tungsten Exploration Results
    May 29, 2026, 7:54 PM EDT. Red Mountain Mining Limited (ASX:RMX) has retracted previous historical exploration results concerning tungsten mineralisation at its Pioneer Tungsten Project in Montana. The company acknowledged inaccuracies in earlier announcements and clarified the data to better reflect the project's status. This correction impacts investors tracking tungsten, a key metal used in industrial applications, and highlights the importance of verified exploration data in mining equity valuations.